STOCKHOLM, SWEDEN (UroToday.com) - Presented by T. Tammela,1 C. Massard,2 P. Bono,3 P. Langmuir,4 J. Aspegren,5 A. Vuorela,5 M.V.J. Mustonen,5 and K. Fizazi2 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
1Tampere University Hospital, Dept. of Urology, Tampere, Finland, 2Institute Gustave Roussy, University of Paris Sud, Dept. of Cancer Medicine, Villejuif, France, 3Helsinki University Hospital, Dept. of Oncology, Helsinki, Finland, 4Endo Pharmaceuticals, Dept. of Clinical Development, Malvern, United States, 5Orion Corporation Orion Pharma, Dept. of Research and Development, Espoo, Finland